EQS-Ad-hoc: SCHOTT Pharma AG Co. KGaA / Key word(s): Forecast/Change in Forecast

SCHOTT Pharma AG Co. KGaA: SCHOTT Pharma specifies FY 2025 guidance for revenue growth and EBITDA margin 05-Aug-2025 / 09:53 CET/CEST

Disclosure of an inside information acc. to Article 17 MAR of the…Read More

You might also be interested in reading US Miner Orders 50,000 Avalon A15 Pro Machines From Canaan, Stock Spikes .